Enugu State University of Science and Technology (ESUT) Biomedical Engineering/Technology postgraduate programmes admission form for the 2022/2023 academic session.
Applications are invited from suitably qualified candidates for admission into the Enugu State University of Science and Technology (ESUT) Biomedical Engineering/Technology postgraduate full-time and part-time programmes for the 2022/2023 academic session.
ESUT Biomedical Engineering/Technology Postgraduate Programmes Admission Requirements
The admission requirement for the Doctor of Philosophy and Master’s degree programme in Biomedical Engineering Technology is the possession of at least a good Second Class Degree with a minimum of 3.5 and 3.00 respectively on a 5.00 CGPA points scale. For Postgraduate Diploma (PGD) is the possession of below 3.00 on 5.00 CGPA points scale in Engineering, Medicine, Biosciences/Health Sciences, Computer Science and any other related science career from a renowned degree awarding institution. Admission Consideration is also given to those with HND in relevant field for the PGD programme.
Candidates must possess five credits passes in English, Mathematics, Biology, Chemistry and Physics or any related science subjects at O level certificate in Not more than two sittings.
Duration of ESUT Biomedical Engineering/Technology Postgraduate Programmes
Master Degree/Postgraduate Diploma (PGD) programmes:
- Full-time minimum of (3) semesters and a maximum of (6) semesters
- Part-time minimum of (4) semesters and a maximum of (8) semesters
How to Apply for ESUT Biomedical Engineering/Technology Postgraduate Programmes Admission Form
Interested applicants are to visit the university website www.esut.edu.ng click on the university portal on the top left side of the website, scroll down to POSTGRADUATE PORTAL generate application invoice and follow the procedure until you are done with the application.
START OF COURSE: September, 2022 for 2022/2023 session
For Further Enquiries call: 08037748204, 08063467592, 08033180232
Disclaimer: This article is provided for general information purpose only and may contain data fetched from third party sources; hence, we do not endorse its accuracy. For more details, kindly visit the Source. Please report any fake news or false statement to Our Support Team. If you are the original owner of this content and wish it to be removed on this platform, kindly forward your request to Our Support Team.
